SARS-CoV-2 (COVID-19) ORF7A Recombinant Protein
1232.55 €
In Stock
quantity
product details
Catalog number: 223 - 20-239
Product Category: Business & Industrial > Science & Laboratory
Gentaur
Size: 0.1 mg
10-435
SARS-CoV-2 (COVID-19) ORF7a Recombinant protein
Plays a role as antagonist of host tetherin (BST2), disrupting its antiviral effect. Acts by binding to BST2 thereby interfering with its glycosylation. May suppress small interfering RNA (siRNA). May bind to host ITGAL, thereby playing a role in attachment or modulation of leukocytes.
1184.83 €
9283-002mg
SARS-CoV-2 (COVID-19) ORF7a Antibody
Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). SARS-CoV-2 virus proteins include structural proteins, non-structural proteins and accessory factors. The structure of SARS-CoV-2 consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. SARS-CoV-2 non-structural protein is ORF1ab that consists of 16 proteins (nsp1-nsp16), while accessory factors include ORF3a, ORF3b, ORF6, ORF7a, ORF7b, ORF8, ORF9b, ORF7a and ORF7a. ORF7a plays a role as antagonist of host tetherin (BST2), disrupting its antiviral effect. It acts by binding to BST2 thereby interfering with its glycosylation. It may suppress small interfering RNA (siRNA) and may bind to host ITGAL, thereby playing a role in attachment or modulation of leukocytes (3).
479.30 €
20-193
SARS-CoV-2 (COVID-19) ORF6 Recombinant Protein
SARS-CoV-2 (COVID-19) ORF6 Recombinant Protein
1232.55 €
20-194
SARS-CoV-2 (COVID-19) ORF7B Recombinant Protein
SARS-CoV-2 (COVID-19) ORF7B Recombinant Protein
1232.55 €
20-195
SARS-CoV-2 (COVID-19) ORF3B Recombinant Protein
SARS-CoV-2 (COVID-19) ORF3B Recombinant Protein